
<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/themes/root/assets/xsl/rss.xsl"?>
<rss version="2.0" xmlns:opensearch="http://a9.com/-/spec/opensearch/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/">
  <channel>
    <title>Results for randomised evaluation using</title>
    <description>Showing 1 - 7 results of 7</description>
    <generator>Laminas_Feed_Writer 2 (https://getlaminas.org)</generator>
    <link>https://asren-aggregator.asren.net/Search/Results?sort=last_indexed+desc&amp;limit=50&amp;lookfor=randomised+evaluation+using&amp;type=AllFields&amp;lng=en</link>
    <opensearch:totalResults>7</opensearch:totalResults>
    <opensearch:startIndex>0</opensearch:startIndex>
    <opensearch:itemsPerPage>50</opensearch:itemsPerPage>
    <opensearch:Query role="request" searchTerms="randomised%20evaluation%20using" startIndex="0"/>
    <atom:link rel="first" type="application/rss+xml" title="Go to First Page" href="https://asren-aggregator.asren.net/Search/Results?sort=last_indexed+desc&amp;limit=50&amp;view=rss&amp;lookfor=randomised+evaluation+using&amp;type=AllFields&amp;lng=en"/>
    <atom:link rel="last" type="application/rss+xml" title="Go to Last Page" href="https://asren-aggregator.asren.net/Search/Results?sort=last_indexed+desc&amp;limit=50&amp;view=rss&amp;lookfor=randomised+evaluation+using&amp;type=AllFields&amp;lng=en"/>
    <atom:link rel="self" type="application/rss+xml" href="https://asren-aggregator.asren.net/Search/Results?sort=last_indexed+desc&amp;limit=50&amp;view=rss&amp;lookfor=randomised+evaluation+using&amp;type=AllFields&amp;lng=en"/>
    <item>
      <title>1787 evaluation of transperineal prostatic administration of a PSA-activasted protoxin (PRX302) in men with luts secondary to BPH</title>
      <pubDate>Fri, 01 Jan 2010 18:19:15 -0500</pubDate>
      <link>https://asren-aggregator.asren.net/Record/LAURepo_2abf1b55c1a3d17adcd016075e5a2823</link>
      <guid>https://asren-aggregator.asren.net/Record/LAURepo_2abf1b55c1a3d17adcd016075e5a2823</guid>
      <author>Elhilali, Mostafa</author>
      <dc:format>article</dc:format>
      <dc:date>2010</dc:date>
      <dc:creator>Elhilali, Mostafa</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19</title>
      <pubDate>Fri, 01 Jan 2021 18:19:15 -0500</pubDate>
      <link>https://asren-aggregator.asren.net/Record/LAURepo_cb4189e771d72cdd80286d435314a6a5</link>
      <guid>https://asren-aggregator.asren.net/Record/LAURepo_cb4189e771d72cdd80286d435314a6a5</guid>
      <author>Matli, Kamal</author>
      <dc:format>article</dc:format>
      <dc:date>2021</dc:date>
      <dc:creator>Matli, Kamal</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Bevacizumab for neovascular age-related macular degeneration (ABC trial)</title>
      <pubDate>Wed, 01 Jan 2014 18:19:15 -0500</pubDate>
      <link>https://asren-aggregator.asren.net/Record/LAURepo_d0dad0a60e37fd9ced51dc062b1f9783</link>
      <guid>https://asren-aggregator.asren.net/Record/LAURepo_d0dad0a60e37fd9ced51dc062b1f9783</guid>
      <author>Ghazi, Nicola G.</author>
      <dc:format>article</dc:format>
      <dc:date>2014</dc:date>
      <dc:creator>Ghazi, Nicola G.</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Effectiveness of lipid‐based nutrient supplementation during the first 1000 days of life for early childhood development: A community‐based trial from Pakistan</title>
      <pubDate>Mon, 01 Jan 2024 18:19:15 -0500</pubDate>
      <link>https://asren-aggregator.asren.net/Record/Manara2_185e46865632a97a7692247ddc946d88</link>
      <guid>https://asren-aggregator.asren.net/Record/Manara2_185e46865632a97a7692247ddc946d88</guid>
      <author>Ayesha Imtiaz (18858232)</author>
      <dc:date>2024</dc:date>
      <dc:creator>Ayesha Imtiaz (18858232)</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Participant characteristics are poorly reported in exercise trials in tendinopathy: A systematic review</title>
      <pubDate>Fri, 01 Jan 2021 18:19:15 -0500</pubDate>
      <link>https://asren-aggregator.asren.net/Record/Manara2_4ba45b3d55b5acf822ffad983cdccbd3</link>
      <guid>https://asren-aggregator.asren.net/Record/Manara2_4ba45b3d55b5acf822ffad983cdccbd3</guid>
      <author>Seán Mc Auliffe (8909972)</author>
      <dc:date>2021</dc:date>
      <dc:creator>Seán Mc Auliffe (8909972)</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Clinical Outcomes With Once‐Weekly Insulin Icodec Versus Once‐Daily Insulin Glargine U100 in Insulin‐Naïve and Previously Insulin‐Treated Individuals With Type 2 Diabetes: A Meta‐Analysis of Randomised Controlled Trials</title>
      <pubDate>Mon, 01 Jan 2024 18:19:15 -0500</pubDate>
      <link>https://asren-aggregator.asren.net/Record/Manara2_c6792a00c82ba33e861ed049df6e48e9</link>
      <guid>https://asren-aggregator.asren.net/Record/Manara2_c6792a00c82ba33e861ed049df6e48e9</guid>
      <author>Mushood Ahmed (19231379)</author>
      <dc:date>2024</dc:date>
      <dc:creator>Mushood Ahmed (19231379)</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
    <item>
      <title>Treatment outcomes of pulpotomy versus pulpectomy in vital primary molars diagnosed with symptomatic irreversible pulpitis: protocol for a non-inferiority randomised controlled trial</title>
      <pubDate>Mon, 01 Jan 2024 18:19:15 -0500</pubDate>
      <link>https://asren-aggregator.asren.net/Record/Manara2_cc3b4b8c550e913a61799846ce41e556</link>
      <guid>https://asren-aggregator.asren.net/Record/Manara2_cc3b4b8c550e913a61799846ce41e556</guid>
      <author>Nebu Philip (14779318)</author>
      <dc:date>2024</dc:date>
      <dc:creator>Nebu Philip (14779318)</dc:creator>
      <slash:comments>0</slash:comments>
    </item>
  </channel>
</rss>
